Chong Kun Dang Pharmaceutical Corp
KRX:185750

Watchlist Manager
Chong Kun Dang Pharmaceutical Corp Logo
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Watchlist
Price: 93 300 KRW 0.65% Market Closed
Market Cap: 1.2T KRW
Have any thoughts about
Chong Kun Dang Pharmaceutical Corp?
Write Note

Chong Kun Dang Pharmaceutical Corp
Intangible Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Chong Kun Dang Pharmaceutical Corp
Intangible Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Intangible Assets CAGR 3Y CAGR 5Y CAGR 10Y
Chong Kun Dang Pharmaceutical Corp
KRX:185750
Intangible Assets
â‚©52.5B
CAGR 3-Years
40%
CAGR 5-Years
28%
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Intangible Assets
â‚©169.8B
CAGR 3-Years
28%
CAGR 5-Years
44%
CAGR 10-Years
31%
SK Biopharmaceuticals Co Ltd
KRX:326030
Intangible Assets
â‚©23.6B
CAGR 3-Years
6%
CAGR 5-Years
149%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Intangible Assets
â‚©87.4B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
0%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Intangible Assets
â‚©105.4B
CAGR 3-Years
47%
CAGR 5-Years
40%
CAGR 10-Years
45%
C
Celltrion Pharm Inc
KOSDAQ:068760
Intangible Assets
â‚©6.1B
CAGR 3-Years
-1%
CAGR 5-Years
14%
CAGR 10-Years
-11%
No Stocks Found

Chong Kun Dang Pharmaceutical Corp
Glance View

Market Cap
1.2T KRW
Industry
Pharmaceuticals

Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-12-06. The firm is mainly involved in the production and sale of prescription drugs such as antidiabetic treatments, cerebrovascular disease treatments, hypertension treatments and hyperlipidemia therapies. In addition, the Company provides over the counter (OTC) drugs including penzal, prefermine and modcol; quasi-drugs including insecticides and hair dyes; and health functional food. The firm sells products in domestic and overseas markets.

Intrinsic Value
97 275.99 KRW
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Chong Kun Dang Pharmaceutical Corp's Intangible Assets?
Intangible Assets
52.5B KRW

Based on the financial report for Dec 31, 2023, Chong Kun Dang Pharmaceutical Corp's Intangible Assets amounts to 52.5B KRW.

What is Chong Kun Dang Pharmaceutical Corp's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
28%

Over the last year, the Intangible Assets growth was 95%. The average annual Intangible Assets growth rates for Chong Kun Dang Pharmaceutical Corp have been 40% over the past three years , 28% over the past five years .

Back to Top